Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2013 by Beijing 302 Hospital.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Fu-Sheng Wang, Beijing 302 Hospital Identifier:
First received: June 12, 2013
Last updated: July 23, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)